AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGENUS INC Director's Dealing 2016

Dec 23, 2016

34023_dirs_2016-12-23_965e19a4-66db-45b7-a601-ebafef6a831f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGENUS INC (agen)
CIK: 0001098972
Period of Report: 2016-12-21

Reporting Person: ARMEN GARO H (Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-21	Common Stock	J	78001	$4.19	Disposed	1470882	Direct
2016-12-22	Common Stock	J	152405	$4.06	Disposed	1318477	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4046	Indirect

Footnotes

F1: Represents shares donated to a charitable organization.

F2: Dr. Armen is Chairman of the Board of Managers and a member of Antigenics Holdings LLC ("Holdings") which as of the date of this report owns 4,046 shares of Agenus Inc. common stock. Dr. Armen has a pecuniary interest inonly a portion of the shares held by Holdings and disclaims beneficial ownership to the extent of his pecuniary interest therein.